HYPOCELLULAR MYELODYSPLASTIC SYNDROMES (MDS) - NEW PROPOSALS

被引:129
|
作者
TUZUNER, N
COX, C
ROWE, JM
WATROUS, D
BENNETT, JM
机构
[1] UNIV ROCHESTER, CTR CANC, DEPT BIOSTAT PATHOL, MED ONCOL UNIT, ROCHESTER, NY 14642 USA
[2] UNIV ROCHESTER, SCH MED & DENT, DEPT MED, HAEMATOL UNIT, ROCHESTER, NY 14642 USA
关键词
MYELODYSPLASTIC SYNDROMES; HYPOCELLULAR MDS; APLASTIC ANEMIA;
D O I
10.1111/j.1365-2141.1995.tb05356.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine whether hypocellular MDS differs from normo/hypercellular MDS, we attempted to identify hypocellular MDS cases either by correcting the bone marrow (BM) cellularity by age (28 patients) or by using a single arbitrary value of BM cellularity (25 patients) and compared these two groups of hypocellular cases to the normo/hypercellular MDS cases (72 patients). 18 patients were common to both hypocellular groups. Patients with hypocellular MDS in both of these selected groups have similar features with regard to age and sex distribution, peripheral blood and bone marrow parameters, FAB subtypes, karyotypes, leukaemic transformation, and survival. However, the median age of patients in <30% BM cellularity group was higher than those patients in the age-corrected group (69 years v 62 years). The selection of <30% cellularity excluded 10 cases in the age group <70 years but included another seven patients in the age group of >70 years, However, correction of BM cellularity by age revealed that those included patients (selected for <30% cellularity) who had normocellular BM by their age. Therefore we recommend the age-correcting grouping to ensure comparable series for comparison, for response to treatment, and survival. Finally, BM cellularity does not appear to be an important factor on prognosis in MDS, because patients with hypocellular MDS in both selected groups have similar prognosis to those with normo/hypercellular MDS patients.
引用
收藏
页码:612 / 617
页数:6
相关论文
共 50 条
  • [1] Immunological derangement in Hypocellular Myelodysplastic Syndromes
    Serio, B.
    Risitano, A. M.
    Giudice, V.
    Montuori, N.
    Selleri, C.
    [J]. TRANSLATIONAL MEDICINE AT UNISA, 2014, 8 : 31 - 42
  • [2] New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types
    Strupp, Corinna
    Nachtkamp, Kathrin
    Hildebrandt, Barbara
    Giagounidis, Aristoteles
    Haas, Rainer
    Gattermann, Norbert
    Bennett, John M.
    Aul, Carlo
    Germing, Ulrich
    [J]. LEUKEMIA RESEARCH, 2017, 57 : 78 - 84
  • [3] Biologic characteristics of patients with hypocellular myelodysplastic syndromes
    Goyal, R
    Qawi, H
    Ali, I
    Dar, S
    Mundle, S
    Shetty, V
    Mativi, Y
    Allampallam, K
    Lisak, L
    Loew, J
    Venugopal, P
    Gezer, S
    Robin, E
    Rifkin, S
    Raza, A
    [J]. LEUKEMIA RESEARCH, 1999, 23 (04) : 357 - 364
  • [4] Myelodysplastic syndromes (MDS)
    Reinhard Stauder
    [J]. memo - Magazine of European Medical Oncology, 2009, 2 (2) : 108 - 109
  • [5] Myelodysplastic syndromes (MDS)
    Stauder, R.
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (02) : 108 - 109
  • [6] Myelodysplastic syndromes (MDS)
    Germing, U.
    Kuendgen, A.
    Haas, R.
    Gattermann, N.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (05) : 183 - 185
  • [7] Myelodysplastic syndromes (MDS)
    Burgstaller S.
    [J]. memo - Magazine of European Medical Oncology, 2014, 7 (3) : 134 - 137
  • [8] Hypocellular myelodysplastic syndromes - Clinical and biological significance
    Marisavljevic, D
    Cemerikic, V
    Rolovic, Z
    Boskovic, D
    Colovic, M
    [J]. MEDICAL ONCOLOGY, 2005, 22 (02) : 169 - 175
  • [9] NEW GERMLINE TERT GENE MUTATIONS IN APLASTIC ANEMIA/HYPOCELLULAR MYELODYSPLASTIC SYNDROMES
    Matteucci, C.
    Iannotti, T.
    Nofrini, V.
    Brandimarte, L.
    Pierini, V.
    Barba, G.
    Di Battista, V.
    Arcioni, F.
    La Starza, R.
    Aversa, F.
    Mecucci, C.
    [J]. HAEMATOLOGICA, 2014, 99 : 85 - 86
  • [10] Biologic characteristics of patients with hypocellular myelodysplastic syndromes.
    Goyal, R
    Qawi, H
    Ali, SI
    Dar, S
    Mundle, S
    Ahmed, B
    Quadri, M
    Naseer, OB
    Andrews, C
    Shetty, V
    Mativi, B
    Altampallam, K
    Lisak, L
    Loew, J
    Venugopal, P
    Gezer, S
    Robin, E
    Rifkin, S
    Raza, A
    [J]. BLOOD, 1998, 92 (10) : 629A - 629A